3-Bromo-5-(bromomethyl)-6-nitro-1-trityl-1H-indazole

Catalog No.: 
ACHGVF475
CAS No.: 
1695537-84-8
Molecular Formula: 
C27H19Br2N3O2
Molecular Weight: 
577.28
3-Bromo-5-(bromomethyl)-6-nitro-1-trityl-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$775.00InquiryInquiry
100mg95%$1115.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-(bromomethyl)-6-nitro-1-trityl-1H-indazole
IUPAC Name3-bromo-5-(bromomethyl)-6-nitro-1-trityl-1H-indazole
MDL No.MFCD29059374
Molecular FormulaC27H19Br2N3O2
Molecular Weight577.28
SMILESO=[N+](C1=CC2=C(C=C1CBr)C(Br)=NN2C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)[O-]
InChI KeyFGULZLMVWDAETK-UHFFFAOYSA-N
Synonym3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole;3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole(WXC01820);1H-Indazole, 3-bromo-5-(bromomethyl)-6-nitro-1-(triphenylmethyl)-;3-bromo-5-(bromomethyl)-6-nitro-1-tritylindazole
CAS No.1695537-84-8

Synthetic Route by SureRoute

1. ACHGVF475 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGVF475 route product structure diagram
    ACHGVF4751695537-84-8
Inquiry

2. ACHGVF475 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGVF475 route product structure diagram
    ACHGVF4751695537-84-8
Inquiry

3. ACHGVF475 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGVF475 route product structure diagram
    ACHGVF4751695537-84-8
Inquiry

Comments (0)